Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.
Gilead Sciences (GILD) has been one of the most searched-for stocks ... During this period, the Zacks Medical - Biomedical and Genetics industry, which Gilead falls in, has lost 1.9%. The key question ...
Gilead Sciences (NASDAQ:GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention ...
With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...